Viewing Study NCT00902304


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-26 @ 4:18 PM
Study NCT ID: NCT00902304
Status: COMPLETED
Last Update Posted: 2012-12-04
First Post: 2009-04-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Valsartan Intensified Primary Care Reduction of Blood Pressure Study
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CVAL489AAU01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View